回复Heidi Pharo， Hege Marie Vedeld， Rolf Wahlqvist和Guro E. Lind给编辑的信：Thomas Dreyer， Simone Brandt， Knud Fabrin等人。使用Xpert膀胱癌监测尿液生物标志物测试指导膀胱镜检查高度非肌肉侵袭性膀胱癌：来自随机对照DaBlaCa-15试验的结果欧元2025；88:23-30

IF 25.2 1区医学 Q1 UROLOGY & NEPHROLOGY

European urology Pub Date : 2025-09-26 DOI:10.1016/j.eururo.2025.09.4129

Thomas Dreyer, Jørgen Bjerggaard Jensen

引用次数: 0

摘要

没有抽象的

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Reply to Heidi Pharo, Hege Marie Vedeld, Rolf Wahlqvist, and Guro E. Lind’s Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23–30

No Abstract

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European urology 医学-泌尿学与肾脏学

CiteScore

43.00

自引率

2.60%

发文量

1753

审稿时长

23 days

期刊介绍： European Urology is a peer-reviewed journal that publishes original articles and reviews on a broad spectrum of urological issues. Covering topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, the journal also highlights recent advances in techniques, instrumentation, surgery, and pediatric urology. This comprehensive approach provides readers with an in-depth guide to international developments in urology.